Quest Diagnostics Inc (N:DGX)

Business Focus: Healthcare Facilities & Services

Aug 03, 2020 04:05 pm ET
Quest Diagnostics Completes Acquisition of Mid America Clinical Laboratories, Now Provides Professional Lab Management for Nearly 30 Hospitals of Community Health Network and Ascension St. Vincent in
SECAUCUS, N.J. and INDIANAPOLIS, Aug. 3, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of its joint venture partners' interests in Mid America Clinical Laboratories ("MACL"). ...
Aug 03, 2020 08:30 am ET
Quest Diagnostics Launches Automated Next Generation Sequencing (NGS) Engine To Power AncestryHealth®
SECAUCUS, N.J., Aug. 3, 2020 /PRNewswire/ -- A new innovation in advanced genetic sequencing automation from Quest Diagnostics (NYSE: DGX) will now enable individuals to access highly accurate genetic testing providing insights into inherited diseases including cancers of the breast, colon and other conditions through AncestryHealth®....
Jul 29, 2020 04:10 pm ET
FDA Authorizes New Quest Diagnostics Lab Method Designed to Increase COVID-19 Molecular Diagnostics Capacity
SECAUCUS, N.J., July 29, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for a new laboratory technique that speeds the process of extracting viral RNA from specimens* and will enable the company to expand its daily capacity of COVID-19 molecular diagnostic tests on behalf of patients in the United States. ...
Jul 23, 2020 06:45 am ET
Quest Diagnostics Reports Second Quarter 2020 Financial Results
SECAUCUS, N.J., July 23, 2020 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2020, which are consistent with the preliminary results reported on July 13, 2020. ...
Jul 18, 2020 01:30 pm ET
FDA Authorizes Quest Diagnostics COVID-19 Diagnostic Testing for Specimen Pooling for Emergency Use
SECAUCUS, N.J., July 18, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to use specimen pooling with its proprietary molecular diagnostic test for COVID-19. Quest is the first lab provider to receive FDA authorization for the technique for COVID-19 testing in the United States.  ...
Jul 15, 2020 08:01 am ET
Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Third Consecutive Year
SECAUCUS, N.J., July 15, 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2020 Disability Equality Index (DEI) "Best Places to Work for Disability Inclusion" by Disability:IN and the American Association of People with Disabilities (AAPD). ...
Jul 13, 2020 06:45 am ET
Quest Diagnostics Announces Preliminary Second Quarter 2020 Financial Results
SECAUCUS, N.J., July 13, 2020 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today preliminary financial results for the second quarter ended June 30, 2020.  The results reflect stronger than forecasted recovery in base testing volumes (excluding COVID-19 molecular and antibody testing) as well as growing demand for COVID-19 testing services.  ...
Jul 08, 2020 07:03 am ET
HPV Test Misses Twice as Many Women Who Develop Cervical Cancer as Cotesting, Quest Diagnostics Health Trends™ Study Finds
SECAUCUS, N.J., July 8, 2020 /PRNewswire/ -- A Health Trends™ study from researchers at Quest Diagnostics (NYSE: DGX) and the University of Pittsburgh Medical Center (UPMC) provides new evidence that the HPV screening test is significantly less likely to detect cervical cancer and precancer than cotesting, a method which combines HPV and Pap (Papanicolaou test by liquid based cytology) testing using the same specimen. ...
Jun 30, 2020 08:35 am ET
Quest Diagnostics Marks 10 Years of Commitment to Reducing Employee Cancer Risk as CEO Cancer Gold Standard™ Employer
SECAUCUS, N.J., June 30, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, marks its 10-year anniversary as a CEO Cancer Gold Standard™ employer this year, signifying its commitment to implementing employee health strategies that will reduce cancer risk among its workforce. ...
Jun 29, 2020 07:19 am ET
CEO Roundtable on Cancer Celebrates Employers marking Ten-Year CEO Cancer Gold Standard™ Anniversary
CARY, N.C., June 29, 2020 /PRNewswire/ -- The CEO Cancer Gold Standard™, the employer-led health and wellness accreditation program of the CEO Roundtable on Cancer, is now helping more than seven million employees and their family members prevent and address cancer through workplace-based programming. This year, 18 Gold Standard employers mark their ten-year anniversary as Gold Standard employers, having maintained a strong commitment to the health of their employees and satisfying the latest, comprehensive requirements of the Gold Standard. ...
Jun 23, 2020 04:05 pm ET
Quest Diagnostics to Expand in Indiana with Acquisition of Outreach Lab Businesses of Community Health Network and Ascension St. Vincent Now Serviced Through Mid America Clinical Laboratories
SECAUCUS, N.J. and INDIANAPOLIS, June 23, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the formation of a definitive multi-pronged agreement designed to optimize the delivery of high quality, innovative diagnostic laboratory services in Indiana. ...
Jun 15, 2020 07:30 am ET
Repligen Appoints Carrie Eglinton Manner to Board of Directors
Repligen Corporation (NASDAQ:RGEN) today announced the appointment of healthcare industry executive Carrie Eglinton Manner to its Board of Directors. Ms. Eglinton Manner brings to the director role over 23 years of leadership experience across...
May 29, 2020 10:44 am ET
Quest Diagnostics to Speak at the Jefferies Virtual Healthcare Conference
SECAUCUS, N.J., May 29, 2020 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference.  Mark Guinan, Executive Vice President and CFO and Jim Davis, Executive Vice President, General Diagnostics, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence, and the company's current perspective on the impact of the COVID-19 pandemic. The presentation is scheduled for Wednesday,...
May 29, 2020 07:00 am ET
Home State Health and Quest Diagnostics Team Up to Increase Access to COVID-19 Testing in Underserved Communities
ST. LOUIS, May 29, 2020 /PRNewswire/ -- Home State Health announced a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse transcription polymerase chain reaction (rRT-PCR) COVID-19 testing in critical areas of need in St. Louis. Through this collaboration, Home State will facilitate the distribution of up to 1,000 Quest COVID-19 test kits each week to Affinia Healthcare and People's Health Centers, Federally Qualified Health Centers (FQHCs)....
May 28, 2020 01:06 pm ET
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use
SECAUCUS, N.J., May 28, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the Quest Diagnostics Self-collection Kit for COVID-19 (self-collection kit). The self-collection kit is for individuals to self-collect a nasal specimen at home or in a healthcare setting when determined to be appropriate by a healthcare provider....
May 27, 2020 09:02 am ET
Quest Diagnostics Launches COVID-19 Workforce Testing Services to Help Guide Organizations in Fostering Safer Workplaces as Employees Return to Work
SECAUCUS, N.J., May 27, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched a new suite of Return to Work services built around large-scale workforce COVID-19 testing. The services are designed to help organizations access and act on COVID-19 laboratory insights in order to foster safer workplace environments for their employees as the nation begins to restart the U.S. economy.  ...
May 20, 2020 07:26 am ET
Arkansas Health & Wellness, Arkansas Total Care and Quest Diagnostics Team Up to Increase Access to COVID-19 Testing in Underserved Communities
LITTLE ROCK, Ark., May 20, 2020 /PRNewswire/ -- Arkansas Health & Wellness and Arkansas Total Care announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse transcription polymerase chain reaction (rRT-PCR) COVID-19 testing in critical areas of need in Arkansas. Through this collaboration, Arkansas Health & Wellness and Arkansas Total Care will facilitate the distribution of approximately 1,000 Quest COVID-19 test kits each week to Community Health Centers of Arkansas.  ...
May 18, 2020 04:36 pm ET
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., May 18, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share, payable on July 22, 2020 to shareholders of record of Quest Diagnostics common stock on July 8, 2020....
May 11, 2020 06:07 pm ET
Quest Diagnostics Prices $550 Million of Senior Notes
SECAUCUS, N.J., May 11, 2020 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $550 million aggregate principal amount of its 2.800% senior notes due 2031 under Quest Diagnostics' shelf registration statement. ...
May 11, 2020 08:00 am ET
Ortho Clinical Diagnostics and Quest Diagnostics to Broaden Availability of COVID-19 Antibody Testing
RARITAN, N.J., May 11, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to expand COVID-19 antibody testing to more than 20 Quest laboratories across the U.S....
May 11, 2020 08:00 am ET
Ortho Clinical Diagnostics and Quest Diagnostics to Broaden Availability of COVID-19 Antibody Testing
RARITAN, N.J., May 11, 2020 /CNW/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to expand COVID-19 antibody testing to more than 20 Quest laboratories across the U.S....
May 08, 2020 07:00 am ET
Peach State Health Plan and Quest Diagnostics Team Up to Increase Access to COVID-19 Testing in Underserved Communities
ATLANTA, May 8, 2020 /PRNewswire/ -- Peach State Health announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse transcription polymerase chain reaction (rRT-PCR) COVID-19 testing in critical areas of need Georgia. Through this collaboration, Peach State Health Plan will facilitate the distribution of approximately 1,000 Quest COVID-19 test kits each week to Federally Qualified Health Centers (FQHCs), including The Family Health Centers of Georgia, headquartered in Atlanta and ...
May 05, 2020 04:05 pm ET
Quest Diagnostics to Hold Virtual Annual Meeting of Stockholders
SECAUCUS, N.J., May 5, 2020 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that its 2020 Annual Meeting of Stockholders (the "Annual Meeting") will now be held solely by remote communication through a live, online audio webcast. This decision was made as a result of the public health threat caused by the COVID-19 pandemic, mandated limits on public gatherings and to protect the health and safety of the company's stockholders and employees....
Apr 30, 2020 11:30 am ET
Clinical Genomics Expands Strategic Relationship with Quest Diagnostics and Further Increases Momentum for Innovative First-Line Colorectal Cancer Screening Blood Test
Clinical Genomics (“CG” or the “Company”), a provider of advanced cancer diagnostic solutions, including liquid biopsy tests, today announced key business updates related to Trident, the Company’s first-line Colorectal Cancer (“CRC”) screening...
Apr 29, 2020 07:00 am ET
Centene And Quest Diagnostics Team Up To Increase Access To COVID-19 Testing
ST. LOUIS, April 29, 2020 /PRNewswire/ -- Centene (NYSE: CNC) announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse transcription polymerase chain reaction (rRT-PCR) COVID-19 testing in critical areas of need across the country. Through this collaboration, Centene will facilitate the distribution of 25,000 Quest COVID-19 test kits each week to Federally Qualified Health Centers (FQHCs) in ten states or districts across the country. ...
Apr 28, 2020 09:31 am ET
Thinking about buying stock in Aurora Cannabis, Quest Diagnostics, Tesla, Petmed Express, or American Airlines?
NEW YORK, April 28, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, DGX, TSLA, PETS, and AAL....
Apr 28, 2020 07:06 am ET
Quest Diagnostics Launches Consumer-Initiated COVID-19 Antibody Test Through QuestDirect™
SECAUCUS, N.J., April 28, 2020 /PRNewswire/ -- Beginning today, individuals can purchase COVID-19 antibody testing for themselves online, without visiting a doctor's office, through QuestDirect, the consumer-initiated testing business of Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. ...
Apr 22, 2020 06:45 am ET
Quest Diagnostics Reports First Quarter 2020 Financial Results
SECAUCUS, N.J., April 22, 2020 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2020....
Apr 21, 2020 05:42 pm ET
Quest Diagnostics Begins to Perform COVID-19 Antibody Testing
SECAUCUS, N.J., April 21, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples. With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as well as molecular diagnostic laboratory testing.  ...
Apr 09, 2020 07:00 am ET
CareDx Mobilizes 10,000 Phlebotomists for Home Blood Draws of Transplant Patients with RemoTraC
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announces today the...
Apr 07, 2020 09:45 am ET
Quest Diagnostics To Release First Quarter 2020 Financial Results On April 22
SECAUCUS, N.J., April 7, 2020 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2020 results on Wednesday, April 22, 2020, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Mar 21, 2020 04:15 pm ET
Quest Diagnostics Dedicates Special Hours for Non-COVID-19 Testing for Older and Highly Vulnerable Patients
SECAUCUS, N.J., March 21, 2020 /PRNewswire/ -- Through its "Peace of Mind" program, Quest Diagnostics (NYSE: DGX) is taking extra measures to ensure individuals who are the most vulnerable to adverse COVID-19 outcomes have special VIP-level access to the company's 2,250 patient service centers across the United States.  ...
Nov 14, 2019 07:45 am ET
HDL Cholesterol Function Lab Test Offers Novel Insight into Cardiovascular Disease Risk, Reports Quest Diagnostics at American Heart Association 2019 Scientific Sessions
SECAUCUS, N.J., Nov. 14, 2019 /PRNewswire/ -- A laboratory test that evaluates high-density lipoprotein (HDL) cholesterol function provides unique and novel information for assessing cardiovascular disease risk, according to data presented today (Abstract #1020) by Quest Diagnostics (NYSE: DGX) at the 2019 American Heart Association Scientific Sessions. The study is one of four the company will present at the conference, which runs November 16-18, in Philadelphia (Booth #1502)....
Nov 05, 2019 07:45 am ET
Quest Diagnostics Earns Gold Status in American Heart Association's 2019 Workplace Health Achievement Index
SECAUCUS, N.J., Nov. 5, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2019 Workplace Health Achievement Index, ranking the company's workplace health initiative among the best in the nation. 2019 marks the second year in a row that Quest has earned this distinction....
Oct 22, 2019 06:45 am ET
Quest Diagnostics Reports Third Quarter 2019 Financial Results
SECAUCUS, N.J., Oct. 22, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2019....
Oct 16, 2019 08:02 am ET
Majority of Physicians Fear Another Prescription Drug Crisis, Finds New Quest Diagnostics Health Trends™ Report
SECAUCUS, N.J., Oct. 16, 2019 /PRNewswire/ -- Most primary care physicians (62%) fear the opioid drug crisis will be traded for a new prescription drug crisis and nearly three quarters (72%) worry that chronic pain patients will turn to illicit drugs if they do not have access to prescription opioids, according to a new Health Trends™ report from Quest Diagnostics (NYSE: DGX). Seventy percent of primary care physicians wish they had more training on how to taper their patients off opioids. ...
Oct 04, 2019 03:35 pm ET
Quest Diagnostics To Release Third Quarter 2019 Financial Results On October 22
SECAUCUS, N.J., Oct. 4, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2019 results on Tuesday, October 22, 2019, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Sep 19, 2019 04:05 pm ET
National Business Group on Health Honors Quest Diagnostics with Best Employers: Excellence in Health & Well-Being Award
SECAUCUS, N.J., Sept. 19, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2019 Best Employers: Excellence in Health & Well-Being award, presented by the National Business Group on Health, a non-profit association of more than 440 large U.S. employers. The award cites the 50 U.S. employers with the best workforce health and employee well-being organizational initiatives in the nation. ...
Sep 12, 2019 08:00 am ET
Quest Diagnostics and hc1 Collaborate to Optimize Enterprise-wide Laboratory Testing for Health Systems
SECAUCUS, N.J. and INDIANAPOLIS, Sept. 12, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™ powered by hc1®, an innovative new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization.*  ...
Sep 11, 2019 02:00 pm ET
Workforce Drug Positivity Increases in More Than One-Third of U.S. Industry Sectors Examined, According to Quest Diagnostics Multi-Year Analysis
SECAUCUS, N.J., Sept. 11, 2019 /PRNewswire/ -- One third of U.S. industry sectors experienced year-over-year double-digit increases in workforce drug positivity between 2015 and 2018, according to a new analysis of industry-specific data by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The findings will be presented at the Substance Abuse Program Administrators Association (SAPAA) conference in Philadelphia, PA on September 18, 2019.  ...
Sep 10, 2019 04:02 pm ET
Quest Diagnostics Names Manuel O. Méndez as New Commercial Leader
SECAUCUS, N.J., Sept. 10, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Manuel O. Méndez has been named Senior Vice President and Chief Commercial Officer effective October 7, 2019.  ...
Aug 28, 2019 04:41 pm ET
Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference
SECAUCUS, N.J., Aug. 28, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York.  Stephen Rusckowski, Chairman, President and CEO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Monday, September 9, 2019 at 11:40 a.m. Eastern Time. ...
Aug 23, 2019 02:14 pm ET
Quest Diagnostics to Speak at the Baird 2019 Global Healthcare Conference
SECAUCUS, N.J., Aug. 23, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Baird 2019 Global Healthcare Conference in New York.  Steve Rusckowski, Chairman, President and CEO and Jim Davis, Executive Vice President, General Diagnostics will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Thursday, September 5, 2019 at 11:25 a.m. Eastern Time. ...
Aug 15, 2019 06:45 am ET
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., Aug. 15, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on October 21, 2019 to shareholders of record of Quest Diagnostics common stock on October 4, 2019....
Jul 23, 2019 06:45 am ET
Quest Diagnostics Reports Second Quarter 2019 Financial Results
SECAUCUS, N.J., July 23, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2019....
Jul 23, 2019 06:30 am ET
Quest Diagnostics, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July 23, 2019 / Quest Diagnostics, Inc. (NYSE: DGX) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 23, 2019 at 8:30 AM Eastern Time.
Jul 19, 2019 10:50 pm ET
QUEST DIAGNOSTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Quest Diagnostics Incorporated (NYSE: DGX).
Jul 18, 2019 06:00 am ET
Quest Diagnostics Welcomes New Members to the Global Diagnostics Network (GDN)
SECAUCUS, N.J., July 18, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group of major diagnostic laboratories collaborating to generate enhanced diagnostics insights to improve the delivery of global healthcare. Regional companies LSI Medience, and Strand Life Sciences join Quest and the charter members -- Al Borg Medical Laboratories, Dasa, GC Labs, Healius, KingMed Diagnostics, SYNLAB – as GDN members....
Jul 17, 2019 08:01 am ET
Quest Diagnostics Named one of the "Best Places to Work for Disability Inclusion"
SECAUCUS, N.J., July 17, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality Index (DEI) "Best Places to Work for Disability Inclusion" by Disability:IN and the American Association of People with Disabilities (AAPD).  ...
Jul 17, 2019 06:45 am ET
Catholic Health Services Partners with Quest Diagnostics to Deliver High-Value, Innovative Laboratory Services
SECAUCUS, N.J. and ROCKVILLE CENTRE, N.Y., July 17, 2019 /PRNewswire/ -- Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to enhance the quality and value of diagnostic services to patients and their doctors. Within the new partnership, Quest will provide laboratory and supply chain expertise, as well as perform laboratory reference testing.                      ...
Jul 12, 2019 09:30 am ET
Sharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management
ATLANTA, July 12, 2019 /PRNewswire/ -- Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (NYSE: DGX) have formed a collaboration designed to improve digital health and disease management for a range of health care consumers. ...
Jul 09, 2019 01:48 pm ET
Quest Diagnostics To Release Second Quarter 2019 Financial Results On July 23
SECAUCUS, N.J., July 9, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2019 results on Tuesday, July 23, 2019, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Jun 09, 2019 10:37 pm ET
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Quest Diagnostics Incorporated (NYSE: DGX) and Encourages Quest Diagnostics Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Quest Diagnostics Incorporated (NYSE: DGX). Click here to participate in the action. On June 3, 2019, the Company disclosed that it had been...
Jun 07, 2019 10:50 pm ET
QUEST DIAGNOSTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Quest Diagnostics Incorporated (NYSE: DGX).
May 14, 2019 06:45 am ET
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., May 14, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on July 22, 2019 to shareholders of record of Quest Diagnostics common stock on July 8, 2019....
May 13, 2019 04:15 pm ET
Quest Diagnostics To Speak At The UBS Global Healthcare Conference
SECAUCUS, N.J., May 13, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New York.  Steve Rusckowski, Chairman, President and CEO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, May 21, 2019 at 2:30 p.m. Eastern Time. ...
Apr 23, 2019 06:45 am ET
Quest Diagnostics Reports First Quarter 2019 Financial Results
SECAUCUS, N.J., April 23, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2019....
Apr 22, 2019 03:15 pm ET
Forbes Names Quest Diagnostics One of America's Best Large Employers
SECAUCUS, N.J., April 22, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers of 2019. ...
Apr 18, 2019 09:00 am ET
Quest Diagnostics Launches New Consumer-Initiated STD Tests Through QuestDirect™
SECAUCUS, N.J., April 18, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched three new sexually transmitted disease (STD) laboratory test packages that individuals can purchase online for some of the most prevalent STDs in the United States. The new STD test packages are the first to be offered directly by Quest Diagnostics or any other major national laboratory to allow individuals to purchase tests at their discretion. These new packages have been designed to meet the needs of individuals who want accurate bas...
Apr 11, 2019 09:00 am ET
Workforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis
SECAUCUS, N.J., April 11, 2019 /PRNewswire/ -- The rate of workforce drug positivity hit a fourteen-year high in 2018, according to a new analysis released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. Positivity rates in the combined U.S. workforce increased nearly five percent in urine drug tests (4.2% in 2017 versus 4.4% in 2018), climbing to the highest level since 2004 (4.5%) and are now more than 25 percent higher than the thirty-year low of 3.5 percent recorded between 2010 and 2012. ...
Apr 04, 2019 04:09 pm ET
Quest Diagnostics To Release First Quarter 2019 Financial Results On April 23
SECAUCUS, N.J., April 4, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2019 results on Tuesday, April 23, 2019, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Apr 03, 2019 03:00 pm ET
Quest Diagnostics Presents Supplier Excellence Awards to Four Partners
SECAUCUS, N.J., April 3, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence awards to four companies at its 2019 Supplier Forum....
Apr 01, 2019 07:15 am ET
Quest Diagnostics Achieves Perfect Score On 2019 Human Rights Campaign Corporate Equality Index for Third Consecutive Year
SECAUCUS, N.J., April 1, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a perfect score of 100 from the Human Rights Campaign Foundation on the 2019 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBTQ Equality." ...
Apr 01, 2019 07:00 am ET
Massachusetts Governor Baker Visits State of the Art Quest Diagnostics Marlborough Laboratory
MARLBOROUGH, Mass., April 1, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, hosted Massachusetts Governor Charlie Baker at its state-of-the-art clinical testing laboratory in Marlborough, Massachusetts on Friday, March 29.  ...
Mar 26, 2019 08:00 am ET
Quest Diagnostics to Present New Insights from Genetic Testing at the 2019 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
SECAUCUS, N.J., March 26, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of eight studies at the 2019 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, to be held April 2 – 6, 2019 in Seattle, Wash. (Quest Diagnostics booth 929). These studies by Quest Diagnostics researchers evaluate a broad range of laboratory technologies and best practices for aiding in the evaluation of risk for cancer and other diseases. ...
Mar 07, 2019 04:30 pm ET
Quest Diagnostics Prices $500 Million of Senior Notes
SECAUCUS, N.J., March 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $500 million aggregate principal amount of its 4.200% senior notes due 2029 under the Quest Diagnostics' shelf registration statement....
Mar 07, 2019 10:28 am ET
Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
SECAUCUS, N.J., March 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami.  Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, March 12, 2019 at 10:15 a.m. Eastern Time. ...
Mar 07, 2019 07:50 am ET
Investor Expectations to Drive Momentum within Sea Limited Sponsored ADR, Physicians Realty Trust, Quest Diagnostics, Enbridge, Autohome, and ABB — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Sea Limited Sponsored ADR (NYSE:SE), Physicians Realty Trust (NYSE:DOC), Quest...
Mar 01, 2019 03:30 pm ET
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., March 1, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on April 22, 2019 to shareholders of record of Quest Diagnostics common stock on April 8, 2019....
Feb 27, 2019 05:45 am ET
RMC and Quest Diagnostics to Deliver High-Value, Innovative Lab Services
SECAUCUS, N.J. and ORANGEBURG, S.C., Feb. 27, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center (RMC) of Orangeburg, S.C., are teaming up to enhance the quality and value of diagnostic services for patients and their doctors through a new partnership agreement under which Quest will provide full laboratory management services.  ...
Feb 22, 2019 07:25 am ET
Analysis: Positioning to Benefit within Quest Diagnostics, Autodesk, Agios Pharmaceuticals, AMN Healthcare Services, Vistra Energy, and Helen of Troy — Research Highlights Growth, Revenue, and Consoli
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Quest Diagnostics Incorporated (NYSE:DGX), Autodesk, Inc. (NASDAQ:ADSK),...
Feb 20, 2019 05:45 am ET
Quest Diagnostics Partners With Houston Healthcare to Deliver High-Value, Innovative Laboratory Services
SECAUCUS, N.J. and WARNER ROBINS, Ga., Feb. 20, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Houston Healthcare are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide full laboratory management services for Houston Medical Center and Perry Hospital....
Feb 19, 2019 03:43 pm ET
Quest Diagnostics Elects Denise Morrison to Board of Directors
SECAUCUS, N.J., Feb. 19, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Denise M. Morrison to serve as a director, effective February 18, 2019.  Including Ms. Morrison, the company's Board has 11 members....
Feb 18, 2019 11:00 am ET
Quest Diagnostics Names Gabrielle Wolfson Senior Vice President and Chief Information and Digital Officer
SECAUCUS, N.J., Feb. 18, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Gabrielle Wolfson, a veteran information technology business leader, has been named Senior Vice President and Chief Information and Digital Officer. ...
Feb 14, 2019 05:45 am ET
Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019
SECAUCUS, N.J., Feb. 14, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2018....
Feb 13, 2019 08:00 am ET
Walmart’s Influence in the Healthcare Sector; Spreading Health and Wealth as Vendors Capitalize on Spending
Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at increased quarterly sales for the sector thanks, in no small part, to Walmart. CNBC has reported on how Walmart is looking...
Feb 11, 2019 03:01 pm ET
Quest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories
SECAUCUS, N.J. and COLUMBIA, Mo., Feb. 11, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Laboratories (BBPL), a leading provider of diagnostic and clinical laboratory services in the Midwest. ...
Jan 31, 2019 07:25 am ET
Investor Expectations to Drive Momentum within Old Republic International, Quest Diagnostics, Prudential Financial, The Mosaic, PACCAR, and NEXEO SOLUTIONS — Discovering Underlying Factors of Influenc
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Old Republic International Corporation (NYSE:ORI), Quest Diagnostics...
Jan 22, 2019 10:27 am ET
Quest Diagnostics Named One of 2019 "World's Most Admired Companies" by Fortune Magazine for Fourth Consecutive Year
SECAUCUS, N.J., Jan. 22, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year. ...
Jan 14, 2019 07:09 am ET
More Adults Know Their Multidigit Wi-Fi Password Than Vital Health Information, Including Their Single-Letter Blood Type
SECAUCUS, N.J., Jan. 14, 2019 /PRNewswire/ -- Americans have multiple numbers at their fingertips, but some of the numbers that could be most important to their health are not among them. New research released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic insights, shows that a majority of adults don't know vital health information for them or their family members, but nearly all would like to be able to access their health information online....
Jan 07, 2019 08:40 am ET
Quest Diagnostics To Release Fourth Quarter And Full Year 2018 Financial Results On February 14
SECAUCUS, N.J., Jan. 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2018 results on Thursday, February 14, 2019, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Jan 02, 2019 04:27 pm ET
Quest Diagnostics To Speak At The 37th Annual J.P. Morgan Healthcare Conference
SECAUCUS, N.J., Jan. 2, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare Conference in San Francisco.  Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, January 8, 2019 at 7:30 p.m. Eastern Time. Mr. Rusckowski and Mr. Guina...
Dec 21, 2018 11:30 am ET
Quest Diagnostics Completes Sale of India Diagnostics Services Business to Strand Life Sciences
SECAUCUS, N.J., Dec. 21, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the sale of its India medical diagnostic service business to Strand Life Sciences, a Bangalore-based specialized diagnostics company....
Dec 19, 2018 07:01 am ET
Workforce Drug Positivity Rises by Double-Digits in Almost One-Third of U.S. Industry Sectors Examined, According to New Quest Diagnostics Analysis
SECAUCUS, N.J., Dec. 19, 2018 /PRNewswire/ -- Drug use by the U.S. workforce increased each year -- and by double-digits over two years -- between 2015 and 2017, in five of 16 major U.S. industry sectors analyzed, according to a first-ever analysis of industry-specific data from more than ten million urine drug test results performed by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. ...
Dec 07, 2018 08:30 am ET
Consolidated Research: 2018 Summary Expectations for Comcast, Avnet, NIKE, Helios and Matheson Analytics, Quest Diagnostics, and Nevsun Resources — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Comcast Corporation (NASDAQ:CMCSA), Avnet, Inc. (NASDAQ:AVT), NIKE,...
Dec 04, 2018 05:45 am ET
PAMA is Here, But Most Hospitals are Unaware of Its Impact, Study Finds
SECAUCUS, N.J., Dec. 4, 2018 /PRNewswire/ -- Nearly 80 percent of hospital executives surveyed are not at all familiar, or only somewhat familiar, with the Protecting Access to Medicare Act (PAMA) and its impact on hospitals, according to a survey conducted by Modern Healthcare Custom Media on behalf of Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. ...
Dec 03, 2018 09:00 am ET
Aetna and Ascension Join Five Other Leading Health Care Companies in Blockchain-Driven Effort to Address Health Care Provider Data Issues
Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health care provider demographic data.
Nov 28, 2018 03:30 pm ET
Quest Diagnostics to Discuss Strategic Growth Drivers and Financial Outlook at 2018 Investor Day
SECAUCUS, N.J., Nov. 28, 2018 /PRNewswire/ -- At a meeting with analysts and investors at its Investor Day tomorrow, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, will discuss the company's two-point strategy and range of initiatives underway to accelerate growth and drive operational excellence, and also will outline its near-and long-term financial outlook....
Nov 28, 2018 05:45 am ET
Quest Diagnostics to Build Flagship Laboratory at Visionary Campus in Clifton, New Jersey to Empower Better Health for Patients in Seven States
SECAUCUS, N.J., Nov. 28, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will build a flagship laboratory in Clifton, N.J. to enhance the diagnostic information services it provides to over 40 million people in New Jersey, New York, Pennsylvania, Maryland, Virginia, West Virginia, Delaware and the District of Columbia. ...
Nov 27, 2018 08:00 am ET
Quest Diagnostics to Acquire the Laboratory Services Business of Boyce and Bynum Pathology Laboratories, Expanding Diagnostic Innovation in the Midwest
SECAUCUS, N.J. and COLUMBIA, Mo., Nov. 27, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories (BBPL), a leading provider of diagnostic and clinical laboratory services in the Midwest....
Nov 09, 2018 08:00 am ET
Quest Diagnostics to Showcase New Data at the American Heart Association 2018 Scientific Sessions
SECAUCUS, N.J., Nov. 9, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of three studies at the 2018 American Heart Association Scientific Sessions in Chicago. ...
Nov 08, 2018 08:25 am ET
MyQuest from Quest Diagnostics Now Supports Health Records on iPhone
SECAUCUS, N.J., Nov. 8, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that MyQuest, used by more than six million people to see, store and share their results and health information using a smartphone, tablet or desktop computer, now supports Health Records on iPhone. In addition, Quest recently launched a MyQuest update that provides new features such as direct access testing, the ability to add dependents or other approved users, real-time scheduling and more for patients as they become more engag...
Nov 08, 2018 06:15 am ET
Horizon Expands Laboratory Network, Adding Quest Diagnostics as Preferred Provider
NEWARK, N.J. and SECAUCUS, N.J., Nov. 8, 2018 /PRNewswire/ -- Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) announced today that it is expanding its laboratory network by adding Quest Diagnostics (NYSE: DGX) as an in-network provider of diagnostic information services for 2.8 million members of Horizon BCBSNJ. ...
Nov 07, 2018 05:45 am ET
Quest Diagnostics, a Pioneer in Consumer Health, Expands Offering with Launch of QuestDirect, a Service that Provides Consumers Access to Lab Testing without Visiting a Doctor's Office
SECAUCUS, N.J., Nov. 7, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced the launch of QuestDirect, an enhanced consumer-initiated testing service that empowers patients to manage and take control of their healthcare by ordering health and wellness lab testing from the convenience of their home. ...
Nov 06, 2018 04:08 pm ET
Quest Diagnostics Completes Acquisition of U.S. Laboratory Services Business of Oxford Immunotec
SECAUCUS, N.J. and OXFORD, England and MARLBOROUGH, Mass., Nov. 6, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Oxford Immunotec Global PLC (Nasdaq: OXFD) today announced that Quest Diagnostics has completed its previously announced acquisition of the U.S. laboratory services business of Oxford Immunotec....
Nov 01, 2018 02:38 pm ET
Sonora Quest Laboratories Partners with uMETHOD Health to Advance the Care of Chronic Diseases with Precision Medicine
TEMPE, Ariz., Nov. 1, 2018 /PRNewswire/ -- Sonora Quest Laboratories, Arizona's leading provider of diagnostic testing and information services, has announced a partnership with uMETHOD Health, a health technology company offering the first platform for Alzheimer's disease based on advanced artificial intelligence technology. Through the partnership, healthcare providers will have access to the RestoreU METHOD via Sonora Quest for their patients experiencing memory loss. The platform includes lab tests and individualized care plans to assess and minimize risk of developing Alzheimer's, and t...
Nov 01, 2018 08:18 am ET
Clinical Genomics and Quest Diagnostics extend collaboration to provide InSure® ONE™, a fecal immunochemical test for colorectal cancer screening programs
Clinical Genomics, a leading innovator of tests for colorectal cancer, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a 5-year extension to their U.S. supply agreement for the...
Oct 29, 2018 08:00 am ET
Detailed Research: Economic Perspectives on National CineMedia, James River Group, Carpenter Technology, CarMax, Ritchie Bros. Auctioneers, and Quest Diagnostics — What Drives Growth in Today's Compet
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of National CineMedia, Inc. (NASDAQ:NCMI), James River Group Holdings, Ltd....
Oct 25, 2018 12:30 pm ET
Quest Diagnostics and Marin General Hospital to Improve Access to Innovative Diagnostic Services in Northern California
SECAUCUS, N.J. and GREENBRAE, Calif., Oct. 25, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Marin General Hospital, a not-for-profit, full-service hospital, have entered into a definitive agreement for Quest to acquire the outreach laboratory services operations of Marin General Hospital.  ...
Oct 23, 2018 01:00 pm ET
Quest Diagnostics To Host Investor Day On November 29, 2018
SECAUCUS, N.J., Oct. 23, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday, November 29, 2018 at The InterContinental New York Times Square Hotel at 300 W. 44th St.  ...
Oct 23, 2018 06:45 am ET
Quest Diagnostics Reports Third Quarter 2018 Financial Results
SECAUCUS, N.J., Oct. 23, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2018 and updated its outlook for full-year 2018....
Oct 22, 2018 09:30 am ET
Quest Diagnostics Acquires Hurley Medical Center's Outreach Laboratory Services Operation in Central Michigan
SECAUCUS, N.J. and FLINT, Mich., Oct. 22, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced it has acquired certain assets of the outreach laboratory services operation of Hurley Medical Center, a leading regional provider of healthcare services. ...
Oct 16, 2018 09:00 am ET
Quest Diagnostics to Present New Insights from Genetic Testing at the 2018 American Society of Human Genetics Annual Meeting
SECAUCUS, N.J., Oct. 16, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of four studies at the 2018 American Society of Human Genetics Meeting (ASHG), October 16 – 20, 2018 in San Diego (Quest Diagnostics booth 1514). ...
Oct 10, 2018 04:30 pm ET
Quest Diagnostics Completes Acquisition of Provant Health, Extending Health and Wellness Services
SECAUCUS, N.J., Oct. 10, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its subsidiary, Summit Health Inc. ("Summit"), has completed the previously disclosed acquisition of the assets of Hooper Holmes, Inc. d/b/a Provant Health (OTCMKTS: HPHWQ) ("Provant Health"), a provider of employer health and wellness services focused on whole person wellness and care cost management....
Oct 10, 2018 05:00 am ET
Quest Diagnostics Launches the Global Diagnostics Network (GDN) to Improve Healthcare by Increasing Access to Diagnostic Insights Around the World
SECAUCUS, N.J., Oct. 10, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today jointly with other leading diagnostic services providers the formation and launch of the Global Diagnostics Network (GDN). The GDN is a strategic working group of diagnostic laboratories, each committed to unleashing and sharing local innovation to increase global access to diagnostic science, information, and services - ultimately generating enhanced diagnostic insights to improve the delivery of global healthcare. ...
Oct 09, 2018 09:00 am ET
Quest Diagnostics Earns Gold Status in National Business Group on Health's Best Employers for Healthy Lifestyles Awards
SECAUCUS, N.J., Oct. 9, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it received the Gold Award in the 2018 Best Employers for Healthy Lifestyles awards from the National Business Group on Health (NBGH). The awards recognized 49 employers that have an exceptional commitment to improving the lives of their employees through their overall well-being, productivity and quality of life. The Gold Award is presented to member companies that have a strong commitment to holistic well-being and related metr...
Oct 05, 2018 04:31 pm ET
Quest Diagnostics To Release Third Quarter 2018 Financial Results On October 23
SECAUCUS, N.J., Oct. 5, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2018 results on Tuesday, October 23, 2018, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Oct 05, 2018 04:01 pm ET
Quest Diagnostics to Sell India Diagnostics Business to Strand Life Sciences
SECAUCUS, N.J. and BANGALORE, India, Oct. 5, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement to sell its India medical diagnostics business to Strand Life Sciences, a Bangalore-based specialized diagnostics company. ...
Sep 27, 2018 09:00 am ET
Quest Diagnostics Acquires PhenoPath, Broadening Access to Advanced Diagnostics
SECAUCUS, N.J. and SEATTLE, Sept. 27, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired PhenoPath, a national provider of specialized anatomic pathology (AP) and related services. ...
Sep 26, 2018 04:05 pm ET
Quest Diagnostics Partners With RMC Health System to Deliver High-Value, Innovative Laboratory Services
SECAUCUS, N.J. and ANNISTON, Ala., Sept. 26, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center Health System (RMC), a regional health care provider for a five-county service area in northeast Alabama, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide supply chain expertise, as well as perform laboratory reference testing.    ...
Sep 25, 2018 09:00 am ET
Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
SECAUCUS, N.J. and OXFORD, England and MARLBOROUGH, Mass., Sept. 25, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced the signing of a definitive agreement under which Quest will acquire the U.S. laboratory services business of Oxford Immunotec.  ...
Sep 24, 2018 09:00 am ET
Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics
SECAUCUS, N.J. and WOBURN, Mass., Sept. 24, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a national leader in specialty fertility diagnostic services. ...
Sep 07, 2018 08:29 am ET
Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
SECAUCUS, N.J., Sept. 7, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City.  Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, September 12, 2018 at 10:30 a.m. Eastern Time. ...
Sep 06, 2018 08:02 am ET
Quest Diagnostics Health Trends™ Study Finds Drug Misuse Rates Remain Constant at High Levels, and Dangerous Opioid-related Drug Combining Is Prevalent
SECAUCUS, N.J., Sept. 6, 2018 /PRNewswire/ -- More than half (52 percent) of Americans tested in 2017 misused their prescription drugs, the same rate as in 2016, but the epidemic is shifting beyond prescription opioids to encompass other drugs and dangerous drug combinations, finds a new Health Trends™ report released today by Quest Diagnostics (NYSE: DGX): Drug Misuse in America 2018. ...
Aug 17, 2018 07:00 am ET
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., Aug. 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of record of Quest Diagnostics common stock on October 5, 2018....
Aug 16, 2018 08:30 am ET
Quest Diagnostics Earns Gold Status in American Heart Association's Workplace Health Achievement Index
SECAUCUS, N.J., Aug. 16, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it achieved gold status in the American Heart Association's 2018 Workplace Health Achievement Index, ranking the company's workplace health program among the best in the nation....
Jul 30, 2018 06:45 am ET
New Quest Diagnostics Data Shows Lyme Disease Prevalence Increasing and is Now Present in New U.S. States
SECAUCUS, N.J., July 30, 2018 /PRNewswire/ -- The prevalence of Lyme disease is increasing in the United States, spiking significantly between 2016 and 2017, and has spread to all 50 United States and the District of Columbia, according to a new study released today by Quest Diagnostics (NYSE: DGX). ...
Jul 24, 2018 06:45 am ET
Quest Diagnostics Reports Second Quarter 2018 Financial Results
SECAUCUS, N.J., July 24, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2018....
Jul 17, 2018 08:03 am ET
New Study Reveals Stalled Progress Toward Value-Based Care
SECAUCUS, N.J., July 17, 2018 /PRNewswire/ -- ...
Jul 11, 2018 09:40 am ET
Quest Diagnostics To Release Second Quarter 2018 Financial Results On July 24
SECAUCUS, N.J., July 11, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2018 results on Tuesday, July 24, 2018, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Jun 27, 2018 08:00 am ET
Investor Expectations to Drive Momentum within Coca-Cola European Partners, BorgWarner, Ventas, Red Rock Resorts, GGP Inc., and Quest Diagnostics — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Coca-Cola European Partners PLC (NYSE:CCE), BorgWarner Inc. (NYSE:BWA),...
Jun 25, 2018 10:39 am ET
AARP Invests $60M in the Dementia Discovery Fund to Kick-Start its 'Disrupt Dementia' Campaign
WASHINGTON, June 25, 2018 /PRNewswire-USNewswire/ -- With nearly 10 million new cases of dementia and Alzheimer's disease occurring each year1, and no cure, today AARP launched a new campaign, "Disrupt Dementia." The campaign aims to help drive new diagnostics and treatments for dementias while providing education, support and hope for patients and family caregivers impacted by the physical, emotional and financial stress of dementia....
Jun 23, 2018 10:03 am ET
One Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics Study
SECAUCUS, N.J. and ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- Employer wellness programs that combine laboratory and biometric screening with digital behavioral counseling can significantly reduce employees' risk of developing chronic conditions such as diabetes and cardiovascular disease, according to new research from Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. These data will be presented on Monday, June 25, 2018 at 1 p.m. EDT in a late-breaker presentation (62-LB) at the 78th American Diabetes Association's (ADA) Scientific Sessions i...
Jun 11, 2018 09:01 am ET
Quest Diagnostics Unveils Quanum™ Enterprise Content Solutions, Formerly Named ChartMaxx®
SECAUCUS, N.J., June 11, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled the newest version of its Quanum Enterprise Content Management Solution, featuring Smart Capture® from Ephesoft to increase document value through automated classification and data extraction. In connection with the new product version and to better align its technology portfolio under one brand, Quest is migrating the ChartMaxx® brand into the Quanum™ Solutions portfolio as Quanum Enterprise Content Solutions. Quest had previously marke...
Jun 01, 2018 08:30 am ET
Biotech with Liquid Biopsy for Colorectal Cancer Secures $26 Million in New Funding
Clinical Genomics Technologies Pty Ltd (CG), a leading provider of CRC testing solutions, has completed a $26 million financing.  The proceeds from this financing will be used to commercialize Colvera, a liquid biopsy blood test, for earlier...
May 24, 2018 04:30 pm ET
UnitedHealthcare Establishes Long-Term Strategic Partnership with Quest Diagnostics
UnitedHealthcare and Quest Diagnostics (NYSE: DGX) have established a long-term strategic partnership as the two organizations focus on ways to create more personalized care recommendations and a simpler consumer experience for the more than 48 million people enrolled in UnitedHealthcare plans. Quest will be in network for all UnitedHealthcare plan participants beginning Jan. 1, 20191.
May 23, 2018 08:00 am ET
Physicians Lack the Time and Tools to Discover Hidden Risks in Patients with Chronic Conditions, Finds Study from Quest Diagnostics
SECAUCUS, N.J., May 23, 2018 /PRNewswire/ -- The vast majority of primary care physicians don't have the time or tools to adequately address the needs of their patients with multiple chronic conditions, leaving some patients to struggle with health-related social and behavioral issues on their own, according to new research from Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. ...
May 17, 2018 09:00 am ET
Quest Diagnostics adds Helen Torley to Board of Directors
SECAUCUS, N.J., May 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Helen I. Torley was elected to serve as a director at the company's 2018 Annual Meeting of Stockholders, expanding the Board of Directors to 10 members....
May 14, 2018 06:40 pm ET
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., May 14, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on July 23, 2018 to shareholders of record of Quest Diagnostics common stock on July 9, 2018....
May 11, 2018 07:30 am ET
Report: Exploring Fundamental Drivers Behind Valvoline, KKR & Co., Otonomy, Radian Group, Red Rock Resorts, and Quest Diagnostics — New Horizons, Emerging Trends, and Upcoming Developments
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Valvoline Inc. (NYSE:VVV), KKR Co. L.P. (NYSE:KKR), Otonomy, Inc....
May 08, 2018 09:31 am ET
Workforce Drug Positivity at Highest Rate in a Decade, Finds Analysis of More Than 10 Million Drug Test Results
SECAUCUS, N.J., May 8, 2018 /PRNewswire/ -- Driven by increases in cocaine, methamphetamine and marijuana, drug use by the American workforce remains at its highest rate in more than a decade, according to a new analysis released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. ...
May 07, 2018 03:30 pm ET
Forbes Names Quest Diagnostics One of America's Best Large Employers
SECAUCUS, N.J., May 7, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers of 2018.  ...
May 04, 2018 05:20 pm ET
Quest Diagnostics To Speak At The Deutsche Bank 43rd Annual Health Care Conference
SECAUCUS, N.J., May 4, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 43rd Annual Health Care Conference in Boston. Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, May 9, 2018 at 12:50 p.m. Eastern Time. ...
Apr 19, 2018 06:45 am ET
Quest Diagnostics Reports First Quarter 2018 Financial Results
SECAUCUS, N.J., April 19, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2018....
Apr 09, 2018 09:00 am ET
New Survey: False Beliefs about Sexual Risk, Poor Physician-Patient Communication May Impede STD Screening in Young Women
SECAUCUS, N.J., April 9, 2018 /PRNewswire/ -- Despite record high rates of new cases of sexually transmitted diseases (STDs), young women who are sexually active often don't talk to their clinicians about sex and STD risk, and many aren't being tested for infection or disease as guidelines recommend, according to new research from Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services....
Apr 06, 2018 12:04 pm ET
Quest Diagnostics to Release First Quarter 2018 Financial Results on April 19
SECAUCUS, N.J., April 6, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2018 results on Thursday, April 19, 2018, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Apr 02, 2018 09:00 am ET
Humana, MultiPlan, Optum, Quest Diagnostics and UnitedHealthcare Launch Blockchain-Driven Effort to Tackle Care Provider Data Issues
Five leading health care organizations – Humana (NYSE: HUM), MultiPlan, Quest Diagnostics (NYSE: DGX) and UnitedHealth Group’s (NYSE: UNH) Optum and UnitedHealthcare – today announced that they are launching a pilot program applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health care provider demographic data, a critical, complex and difficult issue facing organizations across the health care system.
Feb 26, 2018 09:02 am ET
Quest Diagnostics and Rutgers University Announce Sports Science Research Collaboration to Advance Athletic Performance
Collaboration will leverage insights from Quest’s Blueprint for Athletes biometric testing service data to examine physiological changes, performance variables in competitive athletes at the newly created Quest Diagnostics Sports Science Laboratory at the Rutgers–New Brunswick Center for Health & Human Performance
Feb 22, 2018 02:10 pm ET
Quest Diagnostics To Speak At The Raymond James 39th Annual Institutional Investors Conference
SECAUCUS, N.J., Feb. 22, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Raymond James 39th Annual Institutional Investors Conference in Orlando. Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, March 6, 2018 at 1:05 p.m. Eastern Time. ...
Feb 01, 2018 04:35 pm ET
Quest Diagnostics Completes Acquisition of MedXM
Transaction expands Quest’s scale and reach in the mobile provider segment and bolsters its extended care capabilities
Feb 01, 2018 07:15 am ET
Quest Diagnostics Incorporated to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 1, 2018 / Quest Diagnostics Incorporated (NYSE: DGX) will be discussing their earnings results in their Q4 Earnings Call to be held on February 1, 2018 at 8:30 AM Eastern Time.
Feb 01, 2018 05:45 am ET
Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter
SECAUCUS, N.J., Feb. 1, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2017....
Jan 23, 2018 08:05 am ET
Quest Diagnostics to Acquire MedXM, Expanding its Health Risk Assessment Services to Close Gaps in Care
SECAUCUS, N.J., Jan. 23, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has formed a definitive agreement to acquire Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services. ...
Jan 22, 2018 08:00 am ET
Research Report Identifies Veeva, TD Ameritrade Holding, Quest Diagnostics, Chesapeake Utilities, Standard Motor Products, and Quaker Chemical with Renewed Outlook — Fundamental Analysis, Calculating
NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Veeva Systems Inc. (NYSE:VEEV), TD Ameritrade...
Jan 19, 2018 09:10 am ET
Quest Diagnostics Named One of 2018 "World's Most Admired Companies" by Fortune Magazine for Third Consecutive Year
SECAUCUS, N.J., Jan. 19, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2018 by Fortune for the third consecutive year. ...
Jan 19, 2018 08:32 am ET
Quest Diagnostics To Release Fourth Quarter And Full Year 2017 Financial Results On February 1
SECAUCUS, N.J., Jan. 19, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2017 results on Thursday, February 1, 2018, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Jan 03, 2018 04:30 pm ET
Quest Diagnostics To Speak At The 36th Annual J.P. Morgan Healthcare Conference
SECAUCUS, N.J., Jan. 3, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence.  The presentation is scheduled for Wednesday, January 10, 2018 at 12:00 p.m. Eastern Time. At 12:30 p.m. Eastern Time, Mr. Rusckowski will be joined by Mark Guinan, Ex...
Dec 12, 2017 07:00 am ET
Quest Diagnostics Completes Acquisition of Shiel Medical Laboratory from Fresenius Medical Care
SECAUCUS, N.J., Dec. 12, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of the Shiel Medical Laboratory business from Fresenius Medical Care, the premier healthcare company focused on delivering the highest quality care to people with renal and other chronic conditions. ...
Dec 11, 2017 10:32 am ET
Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system
SECAUCUS, N.J., Dec. 11, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced its support for a lawsuit filed by the American Clinical Laboratory Association (ACLA) charging that the Centers for Medicare & Medicaid Services (CMS) failed to follow a congressional directive to implement a market-based laboratory payment system. Quest is a member of ACLA. ...
Dec 01, 2017 12:00 pm ET
Quest Diagnostics Completes Acquisition of Cleveland HeartLab and Formalizes R&D Collaboration with Cleveland Clinic
SECAUCUS, N.J. and CLEVELAND, Dec. 1, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of Cleveland HeartLab. Quest will establish a national center of excellence focused on heart disease diagnostics within Cleveland HeartLab's existing 25,000 square-foot clinical laboratory facility in Cleveland....
Nov 29, 2017 05:45 am ET
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., Nov. 29, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on January 24, 2018 to shareholders of record of Quest Diagnostics common stock on January 9, 2018....
Nov 20, 2017 05:36 pm ET
Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests
SECAUCUS, N.J., Nov. 20, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided an update on the impact of the Centers for Medicare and Medicaid Services (CMS) publication of finalized 2018 Medicare reimbursement rates for clinical laboratory tests under the Clinical Lab Fee Schedule (CLFS) pursuant to the Protecting Access to Medicare Act (PAMA) announced November 17, 2017. ...
Nov 13, 2017 08:00 am ET
Clinical Genomics and Quest Diagnostics announce FDA 510(K) clearance of InSure® ONE™
At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programs
Nov 01, 2017 09:00 am ET
Quest Diagnostics to Present New Insights in Autoimmune Disease at the 2017 American College of Rheumatology Meeting
Secaucus, NJ, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that it will present results of five studies at the 2017 American College of Rheumatology (ACR) Annual Meeting, November 3 – 8, 2017 in San Diego....
Nov 01, 2017 09:00 am ET
Quest Diagnostics to Present New Insights in Autoimmune Disease at the 2017 American College of Rheumatology Meeting
Five Presentations Show the Clinical Value of Diagnostic Innovations for Assessing Prevalent Autoimmune Diseases, Including Rheumatoid Arthritis and Lupus
Oct 30, 2017 07:45 am ET
Quest Diagnostics Acquires California Laboratory Associates
SECAUCUS, N.J. and BURBANK, Calif., Oct. 30, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired certain assets of California Laboratory Associates (CLA), a clinical lab network serving patients and providers in the Greater Los Angeles Area. ...
Oct 19, 2017 07:45 am ET
Quest Diagnostics Reports Third Quarter 2017 Financial Results, Updates 2017 Financial Guidance and Reaffirms Long Term Outlook
SECAUCUS, N.J., Oct. 19, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2017....
Oct 18, 2017 05:05 pm ET
Quest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland Clinic
SECAUCUS, N.J. and CLEVELAND, Oct. 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced it has formed a definitive agreement to acquire Cleveland HeartLab, a leader in innovative diagnostic services for managing cardiovascular disease, from  equity investors, including Cleveland Clinic. Quest intends to establish a national center of excellence in diagnostic information services at Cleveland HeartLab's specialized laboratory in Cleveland, Ohio, focused on services that aid in assessing risk and treatment protocols for heart disease, the leading cause of death in the United ...
Sep 29, 2017 10:21 am ET
Quest Diagnostics Completes Acquisition of the Outreach Laboratory Services of Two Hartford HealthCare Hospitals in Connecticut
SECAUCUS, N.J. and HARTFORD, Conn., Sept. 29, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired the outreach lab services operations of two hospitals of Hartford HealthCare (HHC), The William W. Backus Hospital and The Hospital of Central Connecticut. HHC is an integrated health care system with five acute care hospitals in Connecticut....
Sep 28, 2017 05:01 pm ET
Quest Diagnostics To Release Third Quarter 2017 Financial Results On October 19
SECAUCUS, N.J., Sept. 28, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2017 results on Thursday, October 19, 2017, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Sep 28, 2017 08:30 am ET
Quest Diagnostics to Acquire Shiel Medical Laboratory from Fresenius Medical Care
SECAUCUS, N.J., Sept. 28, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will acquire the Shiel Medical Laboratory business from Fresenius Medical Care, the premier healthcare company focused on delivering the highest quality care to people with renal and other chronic conditions. The transaction is structured as a purchase of assets. ...
Sep 28, 2017 08:01 am ET
One in Four Individuals Combine Opioids and Benzodiazepines, a Potentially Lethal Mix, According to Journal of Addiction Medicine Study
SECAUCUS, N.J., Sept. 28, 2017 /PRNewswire/ -- More than 25 percent of patients monitored by lab tests for prescription drug adherence are concurrently taking both opioids and benzodiazepines, according to a new study published online today in the peer reviewed Journal of Addiction Medicine by researchers at Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. ...
Sep 27, 2017 05:15 pm ET
Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes
SECAUCUS, N.J., Sept. 27, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the third quarter of 2017 it expects a reduction in revenues of approximately 1.5% and a reduction in both reported earnings per share and adjusted diluted earnings per share of approximately $0.10 due to recent hurricanes.  The financial impact of these events is primarily attributable to the company's operations in Florida and Texas, states where the company has a proportionately large presence. The financial im...
Sep 22, 2017 08:05 pm ET
Quest Diagnostics Responds to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests
SECAUCUS, N.J., Sept. 22, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, responded today to the Centers for Medicare and Medicaid Services (CMS) publication of proposed 2018 Medicare reimbursement rates for clinical laboratory tests under the Clinical Lab Fee Schedule (CLFS) pursuant to Protecting Access to Medicare Act (PAMA) announced September 22, 2017.  ...
Sep 14, 2017 07:45 am ET
Quest Diagnostics Sustainability Efforts Earn Place on DJSI World Index for Fourteenth Consecutive Year
MADISON, N.J., Sept. 14, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, was named for the thirteenth consecutive year in the North America Dow Jones Sustainability Index (DJSI) and for a fourteenth year in the World DJSI....
Sep 07, 2017 08:00 am ET
Quest Diagnostics Moves to Convenient Nonfasting Cholesterol Testing with Improved Method for Assessing Heart Disease Risk and Aiding Treatment Decisions
SECAUCUS, N.J., Sept. 7, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that all of the company's cholesterol test services that involve estimates of low-density lipoprotein cholesterol (LDL-C) now use a novel calculation shown to improve the accuracy of testing for levels of LDL-C, a key marker of risk of cardiovascular disease.   ...
Sep 06, 2017 03:29 pm ET
Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference
SECAUCUS, N.J., Sept. 6, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City.  Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, September 12, 2017 at 10:35 a.m. Eastern Time....
Sep 06, 2017 11:00 am ET
Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis
MADISON, N.J., Sept. 6, 2017 /PRNewswire/ -- A majority of test results of patients taking prescription medications show signs of drug misuse, including potentially dangerous drug combinations, finds a new large-scale analysis of laboratory test results from Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. ...
Aug 18, 2017 09:00 am ET
Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Aug. 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on October 18, 2017 to shareholders of record of Quest Diagnostics common stock on October 3, 2017....
Aug 01, 2017 12:59 pm ET
Mountainside Fitness Partners with Sonora Quest Laboratories to Offer Customized Wellness Testing to Health Club Members
TEMPE, Ariz., Aug. 1, 2017 /PRNewswire/ -- Mountainside Fitness and Sonora Quest Laboratories have collaborated to offer a select menu of wellness screens and health profiles to Mountainside Fitness members, empowering them to take control of their health by ordering certain lab tests on their own. These tests are available through Sonora Quest Laboratories' My Lab ReQuest service which, per Arizona law, allows consumers to order lab tests from a licensed clinical laboratory without physician orders. ...
Jul 25, 2017 07:45 am ET
Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook
MADISON, N.J., July 25, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2017 and raised its full year 2017 outlook for revenues, diluted EPS and cash provided by operations....
Jul 19, 2017 08:00 am ET
Quest Diagnostics Launches QHerit™, a Pan-Ethnic Genetic Screening Panel Aligned with New Medical Guidelines
MADISON, N.J., July 19, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of QHerit™, a new genetic screening service that provides women and men with insight into their genetic risk of passing on heritable disorders to their offspring. ...
Jul 18, 2017 10:03 am ET
Quest Diagnostics Completes Acquisition of Med Fusion and Clear Point in Texas, Forming National Precision Oncology Center of Excellence
MADISON, N.J., July 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of the laboratory businesses Med Fusion and Clear Point. Operating from a nearly 200,000 square foot facility in Lewisville, Texas, the two businesses form the basis for the company's first national center of excellence in precision diagnostics for oncology. ...
Jul 06, 2017 04:59 pm ET
Quest Diagnostics To Release Second Quarter 2017 Financial Results On July 25
MADISON, N.J., July 6, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2017 results on Tuesday, July 25, 2017, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Jun 27, 2017 02:01 pm ET
Quest Diagnostics Announces Intent to Acquire Cape Cod Healthcare Outreach Laboratory Business in Massachusetts
MADISON, N.J. and HYANNIS, Mass., June 27, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has signed a nonbinding letter of intent to acquire the outreach laboratory services business of Cape Cod Healthcare (CCHC).  The acquisition is subject to review by the Massachusetts Health Policy Commission and completion of a definitive agreement....
Jun 22, 2017 09:00 am ET
Quest Diagnostics Adds Custom Coaching, At-Home Collection to Expand Blueprint for Athletes™ Service
MADISON, N.J., June 22, 2017 /PRNewswire/ -- Fitness devotees and amateur and competitive athletes can now access sports biomarker testing from their home with a suite of expanded capabilities from Blueprint for Athletes, the biomarker testing service from Quest Diagnostics (NYSE: DGX) that gives athletes insights on their own biology to help improve fitness and performance....
Jun 12, 2017 05:03 pm ET
Quest Diagnostics to Form Precision Oncology Center of Excellence Through Acquisition of Two Texas Laboratory Businesses to Serve Oncologists Nationwide
MADISON, N.J., June 12, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that it has signed definitive agreements to acquire two laboratory businesses in Lewisville, Texas, with the aim to establish a center of excellence providing diagnostic services to aid the detection and management of cancer for oncologists and patients nationwide. ...
Jun 08, 2017 10:00 am ET
Data Diagnostics Wins 2017 MedTech Breakthrough Award
MADISON, N.J., June 8, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) announced that their point-of-care health analytics technology Data Diagnostics® won a MedTech Breakthrough Award for Best Overall Healthcare Data Analytics Platform. The MedTech Breakthrough Awards recognize the top companies, people, platforms and products in the health, fitness and medical technology industries. Data Diagnostics is part of the Quest Diagnostics Quanum™ suite of healthcare information and technology solutions....
Jun 06, 2017 10:00 am ET
May 16, 2017 12:10 pm ET
Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., May 16, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on July 24, 2017 to shareholders of record of Quest Diagnostics common stock on July 10, 2017....
May 16, 2017 10:05 am ET
Increases in Illicit Drugs, Including Cocaine, Drive Workforce Drug Positivity to Highest Rate in 12 Years, Quest Diagnostics Analysis Finds
MADISON, N.J., May 16, 2017 /PRNewswire/ -- Drug use in the American workforce, fueled by illicit drugs, reached the highest positivity rate in 12 years, according to an analysis of more than ten million workforce drug test results released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. ...
May 12, 2017 04:21 pm ET
Quest Diagnostics To Speak At The UBS Global Healthcare Conference
MADISON, N.J., May 12, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New York City.  Mark Guinan, Executive Vice President and CFO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, May 23, 2017 at 2:30 p.m. Eastern Time....
May 02, 2017 06:38 pm ET
Quest Diagnostics To Speak At The Deutsche Bank 42nd Annual Health Care Conference
MADISON, N.J., May 2, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 42nd Annual Health Care Conference in Boston. Mark Guinan, Executive Vice President and CFO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, May 3, 2017 at 9:20 a.m. Eastern Time....
May 01, 2017 03:00 pm ET
Quest Diagnostics and PeaceHealth Complete Transaction to Increase Access to Innovative, High-value Diagnostic Information Services in the Pacific Northwest
MADISON, N.J. and VANCOUVER, Wash., May 1, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and PeaceHealth, a mission-based not-for-profit healthcare system, today announced that they have completed a previously announced two-part agreement designed to enhance the delivery of innovative, convenient and high-value diagnostic information services to communities in Oregon, Washington and Alaska. ...
May 01, 2017 12:20 pm ET
Quest Diagnostics CIO Lidia Fonseca Wins 2017 Forbes CIO Innovation Award
MADISON, N.J., May 1, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its senior vice president and chief information officer Lidia L. Fonseca has received a 2017 Forbes CIO Innovation Award. The award, presented during the Forbes Innovation Summit on April 24, recognizes CIOs of multibillion dollar companies who have demonstrated the ability to generate value through innovation. ...
Apr 24, 2017 02:18 pm ET
Data Diagnostics Wins Gold at the 30th Annual Edison Awards
MADISON, N.J., April 24, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) announced that Data Diagnostics®, a point-of-care health analytics technology, won a gold award in the Health and Wellness—Patient Care category at the 2017 Edison Awards, which honor the best innovations and innovators internationally. Data Diagnostics, offered jointly by Quest Diagnostics and Inovalon, is a healthcare analytics technology that provides patient-specific  reports to the physician in the electronic health record (EHR) to help support clinical actions that directly affect ca...
Apr 24, 2017 08:04 am ET
Quest Diagnostics 50th Anniversary: Celebrating a Half Century of Life-Changing Results
MADISON, N.J., April 24, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks. ...
Apr 20, 2017 07:45 am ET
Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook
MADISON, N.J., April 20, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2017 and raised its full year 2017 diluted EPS outlook....
Apr 07, 2017 05:19 pm ET
Quest Diagnostics To Release First Quarter 2017 Financial Results On April 20
MADISON, N.J., April 7, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2017 results on Thursday, April 20, 2017, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  ...
Apr 06, 2017 04:02 pm ET
Quest Diagnostics Presents Supplier Excellence Awards to Five Partners
MADISON, N.J., April 6, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence Awards to five companies at its 2017 Supplier Forum....
Apr 06, 2017 03:23 pm ET
Wolf Popper LLP: Quest Diagnostics And LabCorp Sued For Excessive Charges
NEW YORK, April 6, 2017 /PRNewswire-USNewswire/ -- Wolf Popper LLP announces Quest Diagnostics Inc. (Quest) (NYSE: DGX) and Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) were sued in the United States District Courts in the District of New Jersey (17-cv-1590) and Middle District of North Carolina (17-cv-193), respectively, by classes of customers alleging that these laboratories overcharged for diagnostic tests by billing them fees far in excess of the market rates negotiated at arm's length with third party payers, such as insurance companies.  Plaintiffs had no agreement ...
Mar 07, 2017 04:54 pm ET
Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
MADISON, N.J., March 7, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami. Stephen Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, March 15, 2017 at 8:30 a.m. Eastern Time....
Mar 06, 2017 08:00 am ET
Quest Diagnostics and American Diabetes Association® to Help Identify People at Risk for Type 2 Diabetes
MADISON, N.J., March 6, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, including employer health and wellness screening and health improvement services, announced a unique collaboration with the American Diabetes Association aimed at helping more people understand their risk of developing type 2 diabetes. ...
Feb 21, 2017 07:30 am ET
Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Feb.  21, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on April 19, 2017 to shareholders of record of Quest Diagnostics common stock on April 5, 2017....
Feb 16, 2017 02:45 pm ET
Quest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine
MADISON, N.J., Feb. 16, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2017 by Fortune. ...
Feb 16, 2017 08:22 am ET
Quest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care
MADISON, N.J., Feb. 16, 2017 /PRNewswire/ -- Harvard Pilgrim Health Care now offers physicians Data Diagnostics®, a point-of-care health analytics technology from Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) that is designed to help close costly gaps in care and improve health outcomes....
Feb 15, 2017 03:03 pm ET
Quest Diagnostics and PeaceHealth to Increase Access to Innovative, High-Value Laboratory Services in the Pacific Northwest
MADISON, N.J. and VANCOUVER, Wash., Feb. 15, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and PeaceHealth, a mission-based not-for-profit healthcare system, have formed a two-part arrangement to enhance the delivery of laboratory services to communities in Oregon, Washington and Alaska. ...
Feb 08, 2017 08:00 am ET
Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics
SOUTH SAN FRANCISCO, Calif., Feb. 8, 2017 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic uncertainty, will extend access to its Afirma Gene Expression Classifier (GEC) through an agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The agreement is intended to meet growing physician demand for innovative genomic testing services to improve thyroid cancer diagnosis. ...
Jan 26, 2017 06:45 am ET
Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017
MADISON, N.J., Jan. 26, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2016....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.